TGF-β inhibits CYP17 transcription in H295R cells acting via activin receptor-like kinase 5

Endocrine Research

Volumn 34, Issue 3, 2009, Pages 68-79

  Derebecka Holysz, Natalia ^a,b   Lehmann, Tomasz P ^a   Holysz, Marcin ^a   Trzeciak, Wieslaw H ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b INSTITUTE OF NATURAL FIBRES AND MEDICINAL PLANTS   (Poland)

Author keywords

ALK5; CYP17 Expression; H295R Cells; TGF

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; CYTOCHROME P450 17; CYTOCHROME P450C17; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; STEROID 17,20 LYASE; STEROID 17ALPHA MONOOXYGENASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;

ADRENAL CORTEX CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ACTIVIN RECEPTORS; ADRENAL CORTEX; BENZAMIDES; CELL LINE; CYTOCHROMES B5; DICHLORORIBOFURANOSYLBENZIMIDAZOLE; DIOXOLES; FORSKOLIN; HUMANS; IMIDAZOLES; MAP KINASE KINASE 1; NADPH-FERRIHEMOPROTEIN REDUCTASE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PYRIDINES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; STEROID 17-ALPHA-HYDROXYLASE; TRANSFORMING GROWTH FACTOR BETA;

EID: 70149092533     PISSN: 07435800     EISSN: 15324206     Source Type: Journal    
DOI: 10.1080/07435800903137050     Document Type: Article

References (23)

1. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003; 113:685-700.
2. Moustakas A, Heldin CH. Non-Smad TGF-beta signals. J Cell Sci 2005; 118:3573-3584.
3. Perrin A, Pascal O, Defaye G, Feige JJ, Chambaz EM. Transforming growth factor beta 1 is a negative regulator of steroid 17 alpha-hydroxylase expression in bovine adrenocortical cells. Endocrinology 1991; 128:357-362.
4. Liakos P, Lenz D, Bernhardt R, Feige JJ, Defaye G. Transforming growth factor beta1 inhibits aldos-terone and cortisol production in the human adrenocortical cell line NCI-H295R through inhibition of CYP11B1 and CYP11B2 expression J Endocrinol 2003; 176:69-82.
5. Brand C, Cherradi N, Defaye G, Chinn A, Chambaz EM, Feige JJ, Bailly S. Transforming growth factor beta1 decreases cholesterol supply to mitochondria via repression of steroidogenic acute regulatory protein expression. J Biol Chem 1998; 273:6410-6416.
6. Chung BC, Picado-Leonard J, Haniu M, Bienkowski M, Hall PF, Shively JE, Miller WL. Cytochrome P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues. Proc Natl Acad Sci USA 1987; 84:407-411.
7. Miller WL. Minireview: regulation of steroidogenesis by electron transfer Endocrinology 2005; 146: 2544-2550.
8. Staels B, Hum DW, Miller WL. Regulation of steroidogenesis in NCI-H295 cells: a cellular model of the human fetal adrenal. Mol Endocrinol 1993; 7:423-433.
9. Lebrethon MC, Jaillard C, Naville D, Begeot M, Saez JM. Effects of transforming growth factor-beta 1 on human adrenocortical fasciculata- reticularis cell differentiated functions. J Clin Endocrinol Metab 1994; 79:1033-1039.
10. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. Embo J 1998; 17:3091-3100.
11. Hjelmeland MD, Hjelmeland AB, Sathornsumetee S, Reese ED, Herbstreith MH, Laping NJ, Friedman HS, Bigner DD, Wang XF, Rich JN. SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility. MolCancer Ther 2004; 3:737-745.
12. Doi J, Takemori H, Ohta M, Nonaka Y, Okamoto M. Differential regulation of 3beta-hydroxysteroid dehydrogenase type II and 17alpha-hydroxylase/lyase P450 in human adrenocortical carcinoma cells by epidermal growth factor and basic fibroblast growth factor. J Endocrinol 2001; 168:87-94.
13. Sewer MB, Waterman MR. Adrenocorticotropin/cyclic adenosine 3′,5′-monophosphate-mediated transcription of the human CYP17 gene in the adrenal cortex is dependent on phosphatase activity. Endocrinology 2002; 143:1769-1777.
14. Hanafusa H, Ninomiya-Tsuji J, Masuyama N, Nishita M, Fujisawa J, Shibuya H, Matsumoto K, Nishida E. Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression. J Biol Chem 1999; 274:27161-27167.
15. Huang N, Dardis A, Miller WL. Regulation of cytochrome b5 gene transcription by Sp3, GATA-6, and steroidogenic factor 1 in human adrenal NCI-H295A cells. Mol Endocrinol 2005; 19:2020-2034.
16. Rainey WE, Bird IM, Sawetawan C, Hanley NA, McCarthy JL, McGee EA, Wester R, Mason JI. Regulation of human adrenal carcinoma cell (NCI-H295) production of C19 steroids. J Clin Endocrinol Metab 1993; 77:731-737.
17. Viard I, Jaillard C, Saez JM. Regulation by growth factors (IGF-I, b-FGF and TGF-beta) of proto-oncogene mRNA, growth and differentiation of bovine adrenocortical fasciculata cells. FEBS Lett 1993; 328:94-98.
18. Wickenheisser JK, Nelson-Degrave VL, McAllister JM. Dysregulation of cytochrome P450 17alpha-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005; 90:1720-1727.
19. Zatelli MC, Rossi R, del Senno L, degli Uberti EC. Role of transforming growth factor beta 1 (TGF beta 1) in mediating androgen-induced growth inhibition in human adrenal cortex in vitro. Steroids 1998; 63:243-245.
20. Lafont J, Laurent M, Thibout H, Lallemand F, Le Bouc Y, Atfi A, Martinerie C. The expression of novH in adrenocortical cells is down-regulated by TGFbeta 1 through c-Jun in a Smad-independent manner. J Biol Chem 2002; 277:41220-41229.
21. Wang EY, Ma EY, Woodruff TK. Activin signal transduction in the fetal rat adrenal gland and in human H295R cells. J Endocrinol 2003; 178:137-148.
22. Inman GJ, Nicolas FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ, Hill CS. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 2002; 62:65-74.
23. Derebecka-Holysz N, Lehmann TP, Holysz M, Trzeciak WH. SMAD3 inhibits SF-1-dependent activation of the CYP17 promoter in H295R cells. Mol Cell Biochem 2008; 307:65-71.